Stool test gaps for women, Jalen Hurts’ blood clots, a new women’s health order and training for stronger bones for today's ...
MedPage Today on MSN
Does stool-based test detect colorectal cancer as well in women?
Study finds FIT misses more cancers and precancerous lesions in women at standard threshol ...
Known differences in colorectal cancer characteristics between men and women are also observed in fecal immunochemical tests.
Strength isn't defined by a number on the scales.
Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the ...
A large screening study across 13 regions of Shandong Province, China, finds that a fecal immunochemical test threshold of 25 µg/g detects 96.4% of colorectal cancers while cutting the colonoscopy ...
Fecal immunochemical tests appear more sensitive to colorectal cancer and advanced precancerous lesions in men than women, ...
Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing the critical role of blood-based testing ...
Stool-based colorectal cancer (CRC) screening involves a two-step approach for those with a positive test that includes a ...
Guardant Health's Shield blood test achieved 99% real-world adherence in two rural clinics, far exceeding typical 28-71% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results